Contact
Please use this form to send email to PR contact of this press release:
Zynerba Pharmaceuticals Announces Initiation of Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Zynerba Pharmaceuticals Announces Initiation of Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome
TO: